Merck & Co., Inc. (NYSE:MRK) Faces Challenges Amid Optimistic Price Target
| Show full article |
|
This functionality is available for registred users only
|
-
Full nameMerck&Co Inc
-
Registration countryUSA
-
IndustryPharmaceutical Preparation and Biotechnology
-
М/S&P/F
*** /*** /***









